Your browser doesn't support javascript.
loading
mTOR is a promising therapeutical target in a subpopulation of pancreatic adenocarcinoma.
Utomo, Wesley K; Narayanan, Vilvapathy; Biermann, Katharina; van Eijck, Casper H J; Bruno, Marco J; Peppelenbosch, Maikel P; Braat, Henri.
Afiliación
  • Utomo WK; Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands.
  • Narayanan V; Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands.
  • Biermann K; Department of Pathology, Erasmus MC, Rotterdam, The Netherlands.
  • van Eijck CH; Department of Surgery, Erasmus MC, Rotterdam, The Netherlands.
  • Bruno MJ; Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands.
  • Peppelenbosch MP; Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands. Electronic address: m.peppelenbosch@erasmusmc.nl.
  • Braat H; Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands.
Cancer Lett ; 346(2): 309-17, 2014 May 01.
Article en En | MEDLINE | ID: mdl-24467966
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Sirolimus / Carcinoma Ductal Pancreático / Serina-Treonina Quinasas TOR Límite: Humans Idioma: En Revista: Cancer Lett Año: 2014 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Sirolimus / Carcinoma Ductal Pancreático / Serina-Treonina Quinasas TOR Límite: Humans Idioma: En Revista: Cancer Lett Año: 2014 Tipo del documento: Article País de afiliación: Países Bajos